Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Rehovot
- Most recent report
- 6-K, filed Oct 5, 2026
- Filings on record
- 576 filings
- On EDGAR
- CIK 1614744
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer
Financials 8 of 365
- 6-K Report a foreign issuer made public elsewhere Oct 5, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 9, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 2, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 10, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 7, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 29, 2026
- 6-K Report a foreign issuer made public elsewhere Jun 23, 2026
- 6-K Report a foreign issuer made public elsewhere Jun 11, 2026
Prospectuses and Registrations 8 of 62
- F-3 May 20, 2026
- 424B5 Prospectus supplement for an offering Sep 19, 2025
- 424B4 Final prospectus for an offering Sep 5, 2025
- F-1 Registration statement, foreign issuer Aug 29, 2025
- 424B5 Prospectus supplement for an offering Jan 6, 2025
- 424B5 Prospectus supplement for an offering Dec 4, 2024
- 424B3 Prospectus supplement for an offering Jul 31, 2024
- F-1 Registration statement, foreign issuer Jul 22, 2024
Ownership 8 of 42
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended May 13, 2026
- 3 Insider reported their initial holding Apr 17, 2026
- 3 Insider reported their initial holding Apr 7, 2026
- 3 Insider reported their initial holding Apr 6, 2026
- 3 Insider reported their initial holding Mar 31, 2026
- 3/A Insider reported their initial holding, amended Mar 30, 2026
- 3 Insider reported their initial holding Mar 30, 2026
Other 8 of 107
- EFFECT Notice that a registration became effective Sep 4, 2025
- CORRESP Reply to SEC staff Aug 29, 2025
- CORRESP Reply to SEC staff Aug 29, 2025
- UPLOAD Comment letter from SEC staff Jul 15, 2025
- DRS Draft registration statement, submitted confidentially Jul 10, 2025
- 6-K/A Report a foreign issuer made public elsewhere, amended Mar 10, 2025
- EFFECT Notice that a registration became effective Jul 30, 2024
- CORRESP Reply to SEC staff Jul 26, 2024
Everything here comes from Purple Biotech Ltd.'s own filings on SEC EDGAR. The filing list is rechecked every hour.